Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Patent Issued for Single-Use or Short-Term Nitric Oxide Delivery Device - Medical Product Outsourcing
OEM News

Patent Issued for Single-Use or Short-Term Nitric Oxide Delivery Device

This patent will provide Nu-Med Plus the IP protection to pursue individual nitric oxide treatment options in emergency situations.

 Nu-Med Plus Inc., a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, announced that the U.S. Patent and Trademark Office  has issued U.S. patent #10682486 for a single-use or short-term use nitric oxide inhaler.
 
This patent will provide the company the intellectual property protection to pursue individual nitric oxide treatment options in emergency situations. The company has designed the system to be used in remote or rural areas which may not have access to non-portable equipment. The portable system has the capability to rapidly deliver the prescribed dose of nitric oxide when critical care and instantaneous use is required either within or outside of traditional hospital settings.
 
Typically, nitric oxide delivery devices are large, electronically complex devices that are used primarily in neonatal intensive care units. The importance of nitric oxide as a treatment is well documented in literature, but to date has not seen widespread use because of the bulky delivery equipment designed for hospital use and the high cost of the treatment.
 
Jeff Robins, CEO of Nu-Med Plus, stated, “This published patent is a major accomplishment for our company and can help open new patient markets. We believe that this patent will give our company the opportunity to be on the forefront of re-shaping the inhaled nitric oxide market landscape,”
 
Patent attorney of record is Bao Tran of Tran & Associates. 
 

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters